The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multimodal fully automated predictive model for therapeutic efficacy of first-line cancer immunotherapy based on clinical information and imaging modalities including brain MRI and chest CT images in advanced non-small cell lung cancer.
 
Taichi Miyawaki
No Relationships to Disclose
 
Takehito Shukuya
Honoraria - AMGEN; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo/UCB Japan; Eisai; Kyowa Kirin; Lilly Japan; MSD; Nippon kayaku; Novartis; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical; Takeda
Research Funding - AstraZeneca; Chugai Pharma; MSD; Novartis
 
Kazuhiro Suzuki
No Relationships to Disclose
 
Shiting Xu
No Relationships to Disclose
 
Yusuke Nakamura
No Relationships to Disclose
 
Isana Katayama
No Relationships to Disclose
 
Yukina Shirai
No Relationships to Disclose
 
Hironari Matsuda
No Relationships to Disclose
 
Masahiro Fujioka
No Relationships to Disclose
 
Yosuke Miyashita
No Relationships to Disclose
 
Yoshika Koinuma
No Relationships to Disclose
 
Tetsuhiko Asao
Speakers' Bureau - AstraZeneca; Bristol Myers Squibb; Chugai Pharma; Daiichi Sankyo/UCB Japan; Merck; MSD K.K; Nippon Boehringer Ingelheim; Nippon Boehringer Ingelheim; Nippon Kayaku; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical; Takeda
 
Ryota Kanemaru
No Relationships to Disclose
 
Shoko Shimamura
No Relationships to Disclose
 
Yoichiro Mitsuishi
No Relationships to Disclose
 
Rina Shibayama
No Relationships to Disclose
 
Ken Tajima
No Relationships to Disclose
 
Naoko Shimada
No Relationships to Disclose
 
Yujiro Otsuka
No Relationships to Disclose
 
Kazuhisa Takahashi
Honoraria - Amgen; AstraZeneca; AstraZeneca; BioMerieux Japan Ltd.; Bristol-Myers Squibb Japan; Bristol-Myers Squibb Japan; Chugai Pharma; Chugai Pharma; Daiichi Sankyo; Daiichi Sankyo; Eisai; Kyorin; Kyorin; Lilly Japan; MSD K.K; MSD K.K; Nippon Boehringer Ingelheim; Nippon Boehringer Ingelheim; Nippon Kayaku; Nippon Kayaku; Nobelpharma; Novartis; Ono Pharmaceutical; Ono Pharmaceutical; Pfizer; Pfizer; Sawai Pharmaceutical Co; Sawai Pharmaceutical Co; Shionogi; Shionogi; Taiho Pharmaceutical; Taiho Pharmaceutical; Takeda; Takeda; Thermo Fisher Scientific; Viatris
Speakers' Bureau - AstraZeneca; Chugai Pharma; Chugai Pharma; Kyorin; Novartis; Ono Pharmaceutical
Research Funding - Chugai Pharma; Chugai Pharma; MSD K. K.; MSD K.K; Ono Pharmaceutical; Ono Pharmaceutical